South Carolina Weighs medical cannabis Legalization
South Carolina candidates debate medical cannabis as federal reclassification to Schedule III prompts lawmakers to reassess patient access, regulation
Cannabis news, weed news, marijuana news
South Carolina candidates debate medical cannabis as federal reclassification to Schedule III prompts lawmakers to reassess patient access, regulation
Kanabo Group revises product and delivery plans as UK medical cannabis access shifts under strict pharma rules, tighter prescribing and sector
medical cannabis prescriptions in London rose 105% from 179 in 2021 to 368 in 2025. UK issued 4,204 NHS cannabis medicine scripts in 2025; Sativex made up
medical cannabis patient accounts shift UK views. Releaf survey of 1,669 shows 97% report better quality of life; stories increase disclosure and family
Tilray Medical attends Cannabis Europa London 2026 to discuss medical cannabis policy, trials, patient access and regulation. Panel May 26 at The Barbican.
InterCure reviews US medical cannabis after federal rescheduling to Schedule III; Botanico deal adds U.S. genetics, AI production tech and brand alliances.
Tilray launches ARX, its first premium medical cannabis brand in Germany, grown at Aphria RX in Neumünster with strains sourced from Canada; stock edges up.
Khalifa Kush enters Australia medical cannabis market. Launching premium flower and edibles via pharmacies and clinics across 6 states and 2 territories.
medical cannabis FOI data shows private dispensings in England rose from 278 items (2019) to 663,130 (2024). concentrated prescribing and dataset
Ayotte vetoed a bill allowing dispensaries one on-site greenhouse, keeping New Hampshire’s medical cannabis production off-site and preserving current